Insight Pharmaceuticals launches Sucrets ICE
LANGHORNE, Pa. Insight Pharmaceuticals on Tuesday launched Sucrets ICE—frozen single-use packages that offer relief from sore throats, the company announced.
“Parents will no longer have to struggle with their children to get them to take their sore throat medicine or worry about the potential for choking on a traditional lozenge,” stated Mickael Tukdarian, vice president and general manager, Insight Pharmaceuticals. “Sucrets ICE is delivered as fruit-flavored ice—a form that children are familiar with and enjoy.”
Sucrets ICE contains the active ingredients menthol and pectin and also includes echinacea and zinc.
Available in grape and pomegranate flavors, each package of Sucrets ICE comes with six single-use pouches that freeze in an hour. The product is being marketed for adults and children 3 years of age and older.
MOM Enterprises Launches Morning Sickness Magic
SAN RAFAEL, Calif. MOM Enterprises last week announced the launch of its morning sickness dietary supplement called Morning Sickness Magic.
“This is the first formula to combine B6, ginger, and other anti-nausea ingredients,” stated Roshan Kaderali, registered nurse and developer of the product. “It’s safe for mothers and their unborn babies—obstetricians across the country are recommending it and distributing it to their patients. It’s actually been the best selling morning sickness formula in the U.S. for the past 5 years. We’ve received tons of emails from expectant mothers who are so relieved that their morning sickness has disappeared,” she said.
According to the American College of Obstetricians and Gynecologists, morning sickness affects between as many as 70 percent of women.
Plan B sees increase in Rx-to-OTC availability
NEW YORK Over-the-counter availability of Plan B has increased access to the emergency contraceptive, a survey published in the November issue of the American Journal of Obstetrics & Gynecology reported.
The survey, originally published online June 16, found that only 8 percent of pharmacies were unable to provide Plan B within 24 hours in 2007, as compared to 23 percent of pharmacies that were unable to produce the emergency contraceptive in 2005. And the total refusal rate in 2007 was half that in 2005, 2 percent vs. 4 percent.
The Food and Drug Administration approved the Rx-to-OTC switch of Plan B in 2006.
Pharmacists from Atlanta and Philadelphia were interviewed at 1,087 pharmacies in 2005 and at 795 pharmacies in 2007.